News und Analysen
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website
GAUSSIN Announces World Tour for its Hydrogen-Powered H2 Racing Truck®, Following Success at 2022 Dakar Rally
GAUSSIN (EURONEXT GROWTH ALGAU - FR0013495298), a pioneer in the clean and intelligent transport of goods and people, today announced the world tour of its H2 Racing Truck®, the world's first
Führender Streaming-Dienst auf den Malediven wählt die Plattform von Verimatrix zum Schutz von App, Inhalten und Umsätzen
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von menschenzentrierten Security-Lösungen zum Schutz der vernetzten Welt, meldete heute, dass ECOMXCHANGEMV Pvt Ltd sich für die Verimatrix
Leading Maldivian Streaming Service Selects Verimatrix Platform To Protect App, Content and Revenues
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that ECOMXCHANGEMV Pvt Ltd selected the
New Milestones for NHOA in the US With Kearsarge Energy: 10MWh Storage System Successfully Commissioned and 12MWh of New Contracts Awarded
Regulatory News:
NHOA (NHOA:PA, formerly Engie EPS) is pleased to announce the successful commissioning of a new storage system in the US.
The project, awarded in December 2020, involved the
Poxel Announces PXL065 Granted FDA Fast Track Designation for X-linked Adrenoleukodystrophy
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including
Poxel Reports Financial Update for Cash and Revenue for the Full Year 2021 and Provides Corporate Update
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Verimatrix bringt Secure Delivery Plattform an den Start, die Einnahmensicherung, Flexibilität und Mehrwert für die Sicherung von Inhalten, Anwendungen und Geräten bietet
Verimatrix, (Euronext Paris: VMX), (Paris: VMX), der führende Anbieter von benutzerorientierten Sicherheitslösungen für die moderne vernetzte Welt, meldete heute die Markteinführung der Verimatrix
Verimatrix Launches Secure Delivery Platform to Provide Revenue Protection, Agility and Additive Value for Securing Content, Applications and Devices
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced the launch of the Verimatrix Secure Delivery Platform
Linedata Services: Growth in full-year results EBITDA up 8.9% NET PROFIT up 39.7%
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website
Transgene Appoints Steven Bloom as Chief Business Officer
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, announced today that it has appointed
Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic Cancer
Regulatory News:
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities
Technicolor (TCH): Robust demand with fulfilment issues
Linedata Services: Full-year revenue 2021: €160.2M
Key Shield von Verimatrix erhält Cybersecurity Excellence Award
Pflichtmitteilung:
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von benutzerorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass Key Shield von
Verimatrix Key Shield Wins Cybersecurity Excellence Award
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Verimatrix Key Shield was recognized as a
GAUSSIN Successfully Finishes the Dakar Rally Driving the Most Powerful Hydrogen H2 Racing Truck® Ever Built, Sponsored by ARAMCO
GAUSSIN (ALGAU - FR0013495298), a pioneer in the clean and intelligent transport of goods and people, announces that the H2 Racing Truck®, GAUSSIN's hydrogen-powered truck sponsored by ARAMCO,
NANOBIOTIX Announces Publication of New Preclinical Immunotherapy Data Showcasing the Combination Potential of NBTXR3 With anti-PD-1 and anti-CTLA-4
Regulatory News:
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’) (Paris:NANO) (NASDAQ:NBTX), a late-stage clinical biotechnology company pioneering physics-based approaches to expand
GAUSSIN Group Publishes Its 2021 Revenues
GAUSSIN (ALGAU - FR0013495298) publishes today its consolidated revenues for the fiscal year 2021 (unaudited).
1. Strong acceleration of GAUSSIN Group's growth
The GAUSSIN Group's 2021 turnover
ESI Group und das DesCartes-Programm machen sich an den Umbau von Singapur zur hybriden, ethischen und nachhaltigen "Smart Nation"
Die ESI Group mit Sitz in Rungis, Frankreich, (ISIN-Code: FR0004110310, Tickersymbol: ESI), ein Global Player im Bereich Virtual Prototyping für die Industrie, beteiligt sich am Start des
ESI Group and the DesCartes Program Aiming at Transforming Singapore Into a Hybrid, Ethical and Sustainable Smart Nation
Regulatory News:
ESI Group, Rungis, France, (ISIN Code: FR0004110310, Mnemo: ESI), a global player in virtual prototyping for industries, is collaborating in the launch of the DesCartes project
Transgene and BioInvent Joint JITC Publication Demonstrates the Potential of BT-001 Oncolytic Virus to Provide Therapeutic Benefit Beyond Current Anti-PD1/ Anti-CTLA-4 Immune Checkpoint Blockade
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq
Axway Software: Adjustment to 2021 Annual Forecast
Regulatory News:
In compliance with Regulation (EU) No. 596/2014, Axway (Euronext: AXW.PA) is adjusting its annual revenue forecast for the 2021 financial year. Although Axway is able to confirm
Transgene and PersonGen Announce Collaboration to Evaluate a New Combination Therapy Against Solid Tumors
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and PersonGen BioTherapeutics, a Chinese